How AI is Revolutionizing Cervical Cancer Screening
AI is transforming cervical cancer screening through advanced image recognition, risk prediction models, and improved accessibility.
AI is transforming cervical cancer screening through advanced image recognition, risk prediction models, and improved accessibility.
Cloud-based LIS solutions are becoming popular in the U.S., offering benefits like flexibility and scalability.
Myriad Genetics and MD Anderson Cancer Center are partnering to advance the development of a molecular residual disease (MRD) assay.
The nasal swab test accurately diagnoses asthma endotypes, enabling more precise treatments and advancing research into asthma subtypes.
Researchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.